Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion type Assertion NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_head.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion wasGeneratedBy ECO_0000203 NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_provenance.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion wasDerivedFrom befree-20140225 NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_provenance.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion SIO_000772 23402816 NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_provenance.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion evidence source_evidence_literature NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_provenance.
- NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_assertion description "[These findings indicate that specific inhibition of IGF1R could be a useful therapeutic approach for Type 1 and Type 2 endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP784192.RArQ9kfkTYhdZnuvqY_IBXLjHhqojCeLfMcJkGgLTm7Q0130_provenance.